Pangenomic Health Inc. (CSE:NARA)
Canada flag Canada · Delayed Price · Currency is CAD
1.560
+0.110 (7.59%)
Jul 21, 2025, 3:59 PM EDT

Pangenomic Health Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cost of Revenue
0.670.590.680.520.03-
Upgrade
Gross Profit
-0.67-0.59-0.68-0.52-0.03-
Upgrade
Selling, General & Admin
0.680.671.611.890.630.13
Upgrade
Research & Development
0.01-0.020.250.530.13-
Upgrade
Operating Expenses
0.640.522.043.050.810.13
Upgrade
Operating Income
-1.31-1.11-2.72-3.58-0.85-0.13
Upgrade
Interest Expense
-0.05-0.07-0.04-0-0-0
Upgrade
Interest & Investment Income
00000.020
Upgrade
Currency Exchange Gain (Loss)
-0.04-0.03-0.030.01--
Upgrade
Other Non Operating Income (Expenses)
-0.03-0.04-0.13-0.06-0.02-0
Upgrade
EBT Excluding Unusual Items
-1.43-1.25-2.93-3.63-0.86-0.14
Upgrade
Asset Writedown
----8.36-1.79-
Upgrade
Other Unusual Items
-2.55-2.55-0.04---
Upgrade
Pretax Income
-3.99-3.8-2.97-11.99-2.65-0.14
Upgrade
Net Income
-3.99-3.8-2.97-11.99-2.65-0.14
Upgrade
Net Income to Common
-3.99-3.8-2.97-11.99-2.65-0.14
Upgrade
Shares Outstanding (Basic)
652100
Upgrade
Shares Outstanding (Diluted)
652100
Upgrade
Shares Change (YoY)
193.01%133.39%82.19%177.08%237.00%-
Upgrade
EPS (Basic)
-0.67-0.82-1.49-10.94-6.70-1.19
Upgrade
EPS (Diluted)
-0.67-0.82-1.49-10.94-6.70-1.19
Upgrade
Free Cash Flow
-0.12-0.06-1.57-2.79-1.07-0.04
Upgrade
Free Cash Flow Per Share
-0.02-0.01-0.79-2.54-2.69-0.32
Upgrade
EBITDA
-1.31-1.1-2.71-3.57-0.85-
Upgrade
D&A For EBITDA
0.010.010.010.010-
Upgrade
EBIT
-1.31-1.11-2.72-3.58-0.85-0.13
Upgrade
Advertising Expenses
-0.010.280.50.08-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.